Eurobio Scientific has signed a definitive agreement to acquire CareDx's Lab Products division for €145 million. This acquisition combines Eurobio's GenDx expertise in next-generation sequencing with CareDx's HLA typing and transplant monitoring kits, creating a comprehensive portfolio for transplantation diagnostics. The deal enhances Eurobio's global market presence and accelerates innovation in transplant molecular assays and software. The transaction is subject to regulatory approvals and aims to streamline operations while improving clinical outcomes in transplant diagnostics.
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
Brazil Potash Corp. disclosed a procedural filing by the Brazilian Federal Public Defender’s Office seeking to suspend activities at its Autazes potash project. The filing challenges prior favorable court decisions but does not introduce new facts or...
DT Midstream, Inc. will announce its financial results for the second quarter of 2026 before the market opens on July 30, 2026. The company has scheduled a conference call at 9:00 a.m. ET on the same day to discuss the results. Investors and the publ...
UK GDP grew 0.8% over three months, beating expectations and showing resilience despite geopolitical risks. The FTSE 100 opened lower amid mixed company results, with major takeovers announced for Rotork (£4.1bn by ABB), Gooch & Housego (£345.6m by A...
Bitcoin briefly reached a three-week high near $65,600 before retreating to around $64,000, influenced by lower-than-expected US inflation data and geopolitical tensions. Ethereum also reversed from a six-week peak near $1,950, slipping below $1,900....
